169 related articles for article (PubMed ID: 1715763)
21. Release of immunoreactive human neutrophil proteinase 4, normally and in peritonitis.
Lundberg E; Bergenfeldt M; Ohlsson K
Scand J Clin Lab Invest; 1991 Feb; 51(1):23-9. PubMed ID: 1708522
[TBL] [Abstract][Full Text] [Related]
22. Neutrophil elastase potentiates cathepsin G-induced platelet activation.
Selak MA
Thromb Haemost; 1992 Nov; 68(5):570-6. PubMed ID: 1333649
[TBL] [Abstract][Full Text] [Related]
23. Comparison of properties of membrane bound versus soluble forms of human leukocytic elastase and cathepsin G.
Bangalore N; Travis J
Biol Chem Hoppe Seyler; 1994 Oct; 375(10):659-66. PubMed ID: 7888078
[TBL] [Abstract][Full Text] [Related]
24. Mutants of plasminogen activator inhibitor-1 designed to inhibit neutrophil elastase and cathepsin G are more effective in vivo than their endogenous inhibitors.
Stefansson S; Yepes M; Gorlatova N; Day DE; Moore EG; Zabaleta A; McMahon GA; Lawrence DA
J Biol Chem; 2004 Jul; 279(29):29981-7. PubMed ID: 15131125
[TBL] [Abstract][Full Text] [Related]
25. Degradation of cartilage matrix proteoglycan by human neutrophils involves both elastase and cathepsin G.
Janusz MJ; Doherty NS
J Immunol; 1991 Jun; 146(11):3922-8. PubMed ID: 2033261
[TBL] [Abstract][Full Text] [Related]
26. A cytosolic inhibitor of human neutrophil elastase and cathepsin G.
Thomas RM; Nauseef WM; Iyer SS; Peterson MW; Stone PJ; Clark RA
J Leukoc Biol; 1991 Dec; 50(6):568-79. PubMed ID: 1658173
[TBL] [Abstract][Full Text] [Related]
27. Activation of matrix metalloproteinase 3 (stromelysin) and matrix metalloproteinase 2 ('gelatinase') by human neutrophil elastase and cathepsin G.
Okada Y; Nakanishi I
FEBS Lett; 1989 Jun; 249(2):353-6. PubMed ID: 2544455
[TBL] [Abstract][Full Text] [Related]
28. Effective activation of the proenzyme form of the urokinase-type plasminogen activator (pro-uPA) by the cysteine protease cathepsin L.
Goretzki L; Schmitt M; Mann K; Calvete J; Chucholowski N; Kramer M; Günzler WA; Jänicke F; Graeff H
FEBS Lett; 1992 Feb; 297(1-2):112-8. PubMed ID: 1551416
[TBL] [Abstract][Full Text] [Related]
29. DNA-bound elastase of neutrophil extracellular traps degrades plasminogen, reduces plasmin formation, and decreases fibrinolysis: proof of concept in septic shock plasma.
Cruz DBD; Helms J; Aquino LR; Stiel L; Cougourdan L; Broussard C; Chafey P; Riès-Kautt M; Meziani F; Toti F; Gaussem P; Anglés-Cano E
FASEB J; 2019 Dec; 33(12):14270-14280. PubMed ID: 31682515
[TBL] [Abstract][Full Text] [Related]
30. Specific sensitivity of CD43 to neutrophil elastase.
Remold-O'Donnell E; Parent D
Blood; 1995 Sep; 86(6):2395-402. PubMed ID: 7662987
[TBL] [Abstract][Full Text] [Related]
31. Active site mapping of the serine proteases human leukocyte elastase, cathepsin G, porcine pancreatic elastase, rat mast cell proteases I and II. Bovine chymotrypsin A alpha, and Staphylococcus aureus protease V-8 using tripeptide thiobenzyl ester substrates.
Harper JW; Cook RR; Roberts CJ; McLaughlin BJ; Powers JC
Biochemistry; 1984 Jun; 23(13):2995-3002. PubMed ID: 6380580
[TBL] [Abstract][Full Text] [Related]
32. Cathepsin-G and leukocyte elastase inactivate human tumor necrosis factor and lymphotoxin.
Scuderi P; Nez PA; Duerr ML; Wong BJ; Valdez CM
Cell Immunol; 1991 Jul; 135(2):299-313. PubMed ID: 2036673
[TBL] [Abstract][Full Text] [Related]
33. Neutrophil elastase and cathepsin G: structure, function, and biological control.
Watorek W; Farley D; Salvesen G; Travis J
Adv Exp Med Biol; 1988; 240():23-31. PubMed ID: 3266707
[TBL] [Abstract][Full Text] [Related]
34. Human eosinophils lack human leukocyte elastase.
Wiedow O; Muhle K; Streit V; Kameyoshi Y
Biochim Biophys Acta; 1996 Apr; 1315(3):185-7. PubMed ID: 8611657
[TBL] [Abstract][Full Text] [Related]
35. The inhibition of human neutrophil elastase and cathepsin G by peptidyl 1,2-dicarbonyl derivatives.
Mehdi S; Angelastro MR; Burkhart JP; Koehl JR; Peet NP; Bey P
Biochem Biophys Res Commun; 1990 Jan; 166(2):595-600. PubMed ID: 2302225
[TBL] [Abstract][Full Text] [Related]
36. Neutrophil cathepsin G promotes prothrombinase and fibrin formation under flow conditions by activating fibrinogen-adherent platelets.
Goel MS; Diamond SL
J Biol Chem; 2003 Mar; 278(11):9458-63. PubMed ID: 12524437
[TBL] [Abstract][Full Text] [Related]
37. In vivo effects of neutrophil enzymes on cardiac enzymes.
Delanghe JR; De Buyzere ML
Clin Chem; 1994 Jan; 40(1):163-4. PubMed ID: 8287531
[No Abstract] [Full Text] [Related]
38. Sequence of formation of molecular forms of plasminogen and plasmin-inhibitor complexes in plasma activated by urokinase or tissue-type plasminogen activator.
Thorsen S; Müllertz S; Suenson E; Kok P
Biochem J; 1984 Oct; 223(1):179-87. PubMed ID: 6208894
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of neutrophil elastase by the alpha1-proteinase inhibitor-immunoglobulin A complex.
Adam C; Bieth JG
FEBS Lett; 1996 May; 385(3):201-4. PubMed ID: 8647251
[TBL] [Abstract][Full Text] [Related]
40. The isoforms of human neutrophil elastase and cathepsin G differ in their carbohydrate side chain structures.
Watorek W; van Halbeek H; Travis J
Biol Chem Hoppe Seyler; 1993 Jun; 374(6):385-93. PubMed ID: 8357534
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
